US Patent 7939496 Modified human growth horomone polypeptides and their uses
Patent 7939496 was granted and assigned to Ambrx on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+81 characters)
Article
Patent abstract
Modified growth hormone polypeptide and uses thereof are provided.
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07939496 Modified human growth horomone polypeptides and their uses US Patent 7939496 Modified human growth horomone polypeptides and their uses
Infobox
Patent Number
0793949600
Patent Number
793949600
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079394960
Date of Patent
May 10, 2011
0Patent Application Number
113165340
Date Filed
December 21, 2005
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079394960
Date of Patent
May 10, 2011
0Patent Application Number
113165340
Date Filed
December 21, 2005
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07939496 Modified human growth horomone polypeptides and their uses
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07939496
Date of patent
May 10, 2011
Patent application number
11316534
Date Filed
December 21, 2005
Patent primary examiner
Find more entities like US Patent 7939496 Modified human growth horomone polypeptides and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
